Editorial: Women in cytokines and soluble mediators in immunity

Diana Boraschi; Giselle Penton-Rol; Olukemi Amodu; Marita Troye Blomberg

doi:10.3389/fimmu.2024.1395165

Editorial: Women in cytokines and soluble mediators in immunity

Front Immunol. 2024 Mar 14:15:1395165. doi: 10.3389/fimmu.2024.1395165. eCollection 2024.

Authors

Diana Boraschi^{1

2

3}, Giselle Penton-Rol^{4

5}, Olukemi Amodu⁶, Marita Troye Blomberg⁷

Affiliations

¹ Laboratory Inflammation and Vaccines, Shenzhen Institute of Advanced Technology (SIAT), Chinese Academy of Sciences (CAS), and China-Italy Joint Laboratory of Pharmacobiotechnology for Medical Immunomodulation, Shenzhen, China.
² Institute of Biomolecular Chemistry, National Research Council (CNR), Pozzuoli, Italy.
³ Stazione Zoologica Anton Dohrn, Napoli, Italy.
⁴ Center for Genetic Engineering and Biotechnology (CIGB), Playa, Cuba.
⁵ Department of Physiological Sciences, Professor of Immunology at the Latin American School of Medicine (ELAM), Havana, Cuba.
⁶ Genetics and Molecular Sciences Unit, Institute of Child Health, College of Medicine, University of Ibadan, Ibadan, Nigeria.
⁷ Department Molecular Biosciences, the Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.

No abstract available

Keywords: cytokines; diagnosis; immunity; pathology; soluble mediators; therapy; women.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Cytokines*
Female
Humans
Immunity, Innate*
Inflammation Mediators

Substances

Cytokines
Inflammation Mediators

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. DB was supported by the EU H2020 project PANDORA (GA 671881), the China-Italy NSFC-MAECI bilateral project 82261138630, the Key Collaborative Research Program of the Alliance of International Science Organizations ANSO-CR-KP-2022-01, and the Bill & Melinda Gates Foundation grant INV-059115.